Neuron-Based Gene Expression Study Reveals Insights on Fear and Its Regulation

We're proud to support a new study with our partner McLean Hospital exploring how the expression of a gene may function as a switch to regulate feelings of fear in psychiatric illnesses such as Post-Traumatic Stress Disorder (PTSD).

Learn more about this study from McLean Hospital, and read the study published in Nature Communications.

Share this article:

More from CVB

A Message from CEO Peter Hoehn

CVB President Nicole Harmon, PhD Discusses How Traumatic Brain Injury Has Impacted Her Family

Interview with Bibi Carmouche, BASE Jumper for 22 Jumps Camelback Mountain 2024

Cohen Veterans Bioscience and 22 Jumps Announce Parachuting with Purpose: Recognizing the Crisis of Veterans Suicide as a Result of Traumatic Brain Injury (TBI) and PTSD

About Cohen Veterans Bioscience (CVB)

Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.